Can one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk? Academic Article uri icon

Overview

MeSH Major

  • Biomarkers, Tumor
  • Digital Rectal Examination
  • Early Detection of Cancer
  • Kallikreins
  • Prostate
  • Prostatic Neoplasms

abstract

  • In previously unscreened men, each with indication for biopsy, a statistical model based on kallikrein levels was similar to a clinical model in predicting prostate cancer in a screening setting, outside the day-to-day clinical practice. Whether a clinical approach can be replaced by laboratory analyses or used in combination with decision models (nomograms) is a clinical judgment that may vary from clinician to clinician depending on how they weigh the different advantages and disadvantages (harms, costs, time, invasiveness) of both approaches.

publication date

  • September 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3675187

Digital Object Identifier (DOI)

  • 10.1111/j.1464-410X.2012.11690.x

PubMed ID

  • 23448270

Additional Document Info

start page

  • 602

end page

  • 9

volume

  • 112

number

  • 5